Current Oncology Readership Survey Results Current Oncology recently conducted an online survey which was sent to 3,110 of our readers and we receive


Current Oncology Readership Survey Results

Current Oncology recently conducted an online survey which was sent to 3,110 of our readers and we received 205 (6.6%) responses. Of the respondents, 130 (63.4%) were from Canada, 23 (11.2%) from the USA, and 52 (25.4%) were from other countries.

Readers were asked to select the survey option that best described their readership of Current Oncology. More than half (57.6%, n = 118) of the respondents reported they often read Current Oncology, and will scan the table of contents each issue and read one or more articles. 15.6% (n = 32) of respondents reported they always read the journal, and rely on the publication in their practice.

Respondents were asked to list up to ten Oncology/Cancer journals they consider essential to their practice. Current Oncology ranked high among the most essential journals, behind the Journal of Clinical Oncology, and followed by the New England Journal of Medicine and Cancer.

CO Results

Figure 1: Comparison of the Top 10 “essential” journals listed by our readership. Current Oncology was the second most listed journal.

Respondents were asked to suggest topics they would like to see in Current Oncology. Some of the suggested journal topics included the economics of cancer care, cost-effectiveness analyses, GI cancers, rehabilitation & survivorship, psychosocial oncology, and geriatric oncology. Efforts will be made to address these and other suggested topics in future issues.

The readership survey demonstrates that Current Oncology is well received by the Oncology community. It is through readership surveys that we are able to assess our progress and identify future opportunities for improvement. We are grateful to those who took the time to complete the survey.

All participants who completed the survey were entered into a draw for a chance to win an iPad mini. The winner of the iPad mini is Dr. Ryna Levy-Milne from British Columbia. Congratulations!


Multimed Inc.
Publisher of Current Oncology


Volume 20, Number 1 (February 2013)

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from this issue:


Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 20, Number 2 (April 2013) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:


Dr. Martin Chasen, MBChB, FCP(SA), MPhil(PallMed)
Managing Editor of Current Oncology and Editor of our Cancer Rehabilitation and Survivorship Section

Dr. Martin Chasen is currently the Medical Director, Palliative Care, The Ottawa Hospital Cancer Centre and the Medical Director of the Palliative Rehabilitation Program at the Élisabeth Bruyère Hospital, Ottawa.

Dr. Chasen was born in Pretoria, South Africa and completed his undergraduate training at the University of Pretoria in South Africa, in 1983. He went on to obtain a specialist degree in Internal Medicine and Medical Oncology as well as a Master of Philosophy (Palliative Medicine) at the University of Cape Town, South Africa. Prior to moving to Canada in 2004, Dr. Chasen worked as a medical oncologist in several hospitals/clinics in South Africa and has been active at the international level in the areas of oncology and palliative care. Between 2004 and 2009, Dr. Chasen worked as an oncologist and palliative care physician for the Departments of Medicine and Oncology at McGill University in Montreal. He there after joined the Palliative care and Medical Oncology teams in Ottawa as an Associate Professor at the University of Ottawa. He has authored more than 65 manuscripts in addition to 10 book chapters and over a hundred published abstracts. His chief interest is Cancer/Palliative Rehabilitation and he has been part of the initial team formations in both Montreal and Ottawa. Dr. Chasen has initiated original research on new drugs to combat the anorexia/cachexia syndrome. He is also a reviewer for the Canadian Institute of Health Research (CIHR), Palliative & End-of-Life Care Peer Review Committee. He is the managing editor of Current Oncology and Associate Editor for Supportive Care.


Current Oncology Launches New Section

We would like to welcome Dr. Daniel Rayson to the Current Oncology team. Dr. Rayson will be Editor of the new section entitled “Cancer Narratives: Words Beyond Disease”. Submissions to this section will include creative writing pieces with a cancer-related theme, as well as descriptions of struggles, conflicts, joys and emotions encountered in clinical practice. To submit your manuscript or for more information about this section, please visit our Information for Authors page.

Current Oncology Meets Requirements of the CIHR Policy on Access to Research Outputs

Current Oncology meets the requirements of the CIHR Policy on Access to Research Outputs. All of our articles are freely accessible at immediately upon publication. We also send all articles published in Current Oncology, without further intervention from the author, to PubMed Central (PMC), the National Library of Medicine’s full text article archive. All articles are also mirrored in all PMC sites, including PubMed Central Canada. Manuscripts deposited to PMC are freely available to the public, via the internet, immediately upon publication in the journal.

Current Oncology Introduces Fast Track Publication

Current Oncology now offers authors optional Fast Track Publication Author Fee Premiums. Upon acceptance, the article will be published within 2-4 months. The article can be published in print & online or online only format, depending on the fee paid. For more information, please visit our Information for Authors page.


Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (January 2013)

Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls
Pereira J.
Curr Oncol. 2011 Apr;18(2):e38-45

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
Melosky B, Burkes R, Rayson D, Alcindor T, Shear N, Lacouture M
Curr Oncol. 2009 Jan;16(1):16-26

A primer of bone metastases management in breast cancer patients
Petrut B, Trinkaus M, Simmons C, Clemons M
Curr Oncol. 2008 Jan;15(Suppl 1):S50-7

Most Read Recently* Published Articles at

A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma
Van der Jagt R, Laneuville P, Macdonald D, Stewart D, Christofides A, Sehn LH.
Curr Oncol. 2012 Jun;19(3):160-8

Advances in the management of metastatic breast cancer: options beyond first-line chemotherapy
Ayoub JP, Verma Sh, Verma S.
Curr Oncol. 2012 Apr;19(2):91-105

Personalized medicine in metastatic non-small-cell lung cancer: promising targets and current clinical trials
Black A, Morris D.
Curr Oncol. 2012 Jun;19(Suppl 1):S73-85

*Published within past 12 months


9th Annual Advanced Learning in Palliative Medicine Conference

For physicians with an interest in palliative care

Jun 13-15, 2013 (Thu-Sat)
The Marriott Pinnacle Hotel, Vancouver, BC
Accreditation: Up to 10.75 Mainpro M1 / MOC Section 1 / AMA PRA Category 1 Credits™

For more details click here:

This year’s conference will have a focus on the care of the older adult with multiple comorbidities with a plenary talk from Dr. Diane Meier. Continuing on this theme there will be rational prescribing for older adults with multiple comorbidities, management of wounds and communication with families in difficult situations by both an intensivist Randall Curtis and an ethicist Bashir Jawani. The agenda includes an update on new fentanyl formulations, opioid metabolism genetics in the selection of opioids, opioid intrathecal pumps and new minimally invasive palliative procedures.


Contact Us